Suchergebnisse - "Klein, Katrin"

PubPharm (57)

31

Outcomes and complications following ABO‐incompatible kidney transplantation performed after desensitization by semi‐selective immunoadsorption ‐ a retrospective study

enthalten in: Transplant international | 2019

von Speer, C. | Kälble, F. | Nusshag, C. | +12

32

A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function

enthalten in: Clinical chemistry and laboratory medicine | 2016

von Adamek, M. | Opelz, G. | Klein, K. | +2

33

A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function

enthalten in: Clinical chemistry and laboratory medicine | 2016

von Adamek, M. | Opelz, G. | Klein, K. | +2

34

Tissue expression of aquaporin 2 is correlated to urine output and allograft function in sensitized kidney transplant patients

enthalten in: Transplantation proceedings | [2016]

von Klein, K. | Rübenacker, S. | Schäfer, S. | +8

35

Outcome after interventionel lungvolume reduction with coils (LVRC) dependent from the initial clinical presentation

enthalten in: The European respiratory journal | 2016

von Trautmann, H. | Golowtschenko, N. | Klein, K. | +2

36

Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption

enthalten in: Transplantation | 2015

von Becker, L. | Siebert, D. | Süsal, C. | +11

37

Outcomes following ABO-incompatible kidney transplantation performed after desensitization by nonantigen-specific immunoadsorption

enthalten in: Transplantation | 11 January 2015

von Becker, L. | Siebert, D. | Süsal, C. | +11

38

Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption

enthalten in: Transplantation | 2015

von Becker, L. | Siebert, D. | Süsal, C. | +11

39

Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis

enthalten in: Atherosclerosis. Supplements | 26 January 2013

von Klein, K. | Süsal, C. | Schäfer, S. | +9

40

Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis

enthalten in: Atherosclerosis. Supplements | 2013

von Klein, K. | Süsal, C. | Schäfer, S. | +9